SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027475
Filing Date
2018-11-06
Accepted
2018-11-06 16:42:16
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20180930.htm 10-Q 2048317
2 EX-10.5 xene-ex105_309.htm EX-10.5 74963
3 EX-31.1 xene-ex311_10.htm EX-31.1 18943
4 EX-31.2 xene-ex312_6.htm EX-31.2 19004
5 EX-32.1 xene-ex321_7.htm EX-32.1 11673
6 EX-32.2 xene-ex322_9.htm EX-32.2 11310
  Complete submission text file 0001564590-18-027475.txt   5504184

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xene-20180930.xml EX-101.INS 917602
8 XBRL TAXONOMY EXTENSION SCHEMA xene-20180930.xsd EX-101.SCH 42026
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20180930_cal.xml EX-101.CAL 36663
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20180930_def.xml EX-101.DEF 132664
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20180930_lab.xml EX-101.LAB 297964
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20180930_pre.xml EX-101.PRE 221561
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 181163557
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1